W.R. Berkley Corp’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

W.R. Berkley Corp’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-9,483	Closed	-$2.04M	–	189
2020 Q3	$2.04M	Sell	9,483 -455	-5%	-$98K	0.3%	56
2020 Q2	$2.14M	Sell	9,938 -10,593	-52%	-$2.26M	0.28%	53
2020 Q1	$4.32M	Buy	+20,531	New	+$4.31M	0.51%	53

Other funds holding RVPH

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

W.R. Berkley Corp's RVPH Position: Q4 2020 in Review

W.R. Berkley Corp sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q4 2020, closing a stake of 9,483 shares — an estimated $2.04M sold.

W.R. Berkley Corp first reported a position in RVPH in Q1 2020 and held it in 3 quarters. The position peaked at $4.32M in Q1 2020. 3 funds tracked by Wall St. Rank hold RVPH as of Q4 2020.

W.R. Berkley Corp reported no remaining REVIVA PHARMA HLDGS INC position as of Q4 2020 after selling out during the quarter.
W.R. Berkley Corp sold 9,483 REVIVA PHARMA HLDGS INC shares in Q4 2020, an estimated $2.04M.
W.R. Berkley Corp first reported a position in REVIVA PHARMA HLDGS INC in Q1 2020 and held it in 3 quarters.
W.R. Berkley Corp's REVIVA PHARMA HLDGS INC position peaked at $4.32M in Q1 2020.
3 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2020.

Based on W.R. Berkley Corp's 13F filing for Q4 2020, filed 16 Feb 2021.